Steffen Pietzke - 14 Jul 2021 Form 4 Insider Report for Enovix Corp (ENVX)

Role
Chief Financial Officer
Signature
/s/ Edward J. Hejlek, Attorney-in-Fact for Steffen Pietzke
Issuer symbol
ENVX
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 20:56:40 UTC
Next filing
12 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVX Stock Option (Right to Buy) Award +276,918 276,918 14 Jul 2021 Common Stock 276,918 $9.26 Direct F1, F2, F3
transaction ENVX Stock Option (Right to Buy) Award +71,020 71,020 14 Jul 2021 Common Stock 71,020 $9.26 Direct F1, F4, F5
transaction ENVX Stock Option (Right to Buy) Award +369,226 369,226 14 Jul 2021 Common Stock 369,226 $9.26 Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.
F2 The shares subject to the option are immediately exercisable. 1/5th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 18, 2021, and 1/60th of the shares subject to the option will vest in 48 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
F3 Received in exchange for a stock option to purchase 1,500,000 shares of Legacy Enovix Common Stock.
F4 The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.
F5 Received in exchange for a stock option to purchase 384,700 shares of Legacy Enovix Common Stock.
F6 The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 1, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
F7 Received in exchange for a stock option to purchase 2,000,000 shares of Legacy Enovix Common Stock.